Zobrazeno 1 - 10 of 11 pro vyhledávání: '"John L P, Thompson"'
1
Akademický článek
The evolution of the mitochondrial disease diagnostic odyssey
Autor: John L. P. Thompson, Amel Karaa, Hung Pham, Philip Yeske, Jeffrey Krischer, Yi Xiao, Yuelin Long, Amanda Kramer, David Dimmock, Amy Holbert, Cliff Gorski, Kristin M. Engelstad, Richard Buchsbaum, Xiomara Q. Rosales, Michio Hirano
Publikováno v: Orphanet Journal of Rare Diseases, Vol 18, Iss 1, Pp 1-10 (2023)
Abstract Background Mitochondrial diseases often require multiple years and clinicians to diagnose. We lack knowledge of the stages of this diagnostic odyssey, and factors that affect it. Our goals are to report the results of the 2018 Odyssey2 (OD2)
Externí odkaz: https://doaj.org/article/0ab8185a7bbc4e9d90ca43b00e093ccb
Zobrazit plný text záznamu
3
Akademický článek
Mitochondrial disease patient motivations and barriers to participate in clinical trials.
Autor: Zarazuela Zolkipli-Cunningham, Rui Xiao, Amy Stoddart, Elizabeth M McCormick, Amy Holberts, Natalie Burrill, Shana McCormack, Lauren Williams, Xiaoyan Wang, John L P Thompson, Marni J Falk
Publikováno v: PLoS ONE, Vol 13, Iss 5, p e0197513 (2018)
BACKGROUND:Clinical treatment trials are increasingly being designed in primary mitochondrial disease (PMD), a phenotypically and genetically heterogeneous collection of inherited multi- system energy deficiency disorders that lack effective therapy.
Externí odkaz: https://doaj.org/article/1a22933ebde349409113d28f859963aa
Zobrazit plný text záznamu
4
Akademický článek
Cognitive function in ambulatory patients with systolic heart failure: insights from the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial.
Autor: Susan Graham, Siqin Ye, Min Qian, Alexandra R Sanford, Marco R Di Tullio, Ralph L Sacco, Douglas L Mann, Bruce Levin, Patrick M Pullicino, Ronald S Freudenberger, John R Teerlink, J P Mohr, Arthur J Labovitz, Gregory Y H Lip, Conrado J Estol, Dirk J Lok, Piotr Ponikowski, Stefan D Anker, John L P Thompson, Shunichi Homma, WARCEF Investigators
Publikováno v: PLoS ONE, Vol 9, Iss 11, p e113447 (2014)
We sought to determine whether cognitive function in stable outpatients with heart failure (HF) is affected by HF severity. A retrospective, cross-sectional analysis was performed using data from 2, 043 outpatients with systolic HF and without prior
Externí odkaz: https://doaj.org/article/1cd0956c78da41ab971b08683951666e
Zobrazit plný text záznamu
6
Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients: From the WARCEF Trial
Autor: John R, Teerlink, Min, Qian, Natalie A, Bello, Ronald S, Freudenberger, Bruce, Levin, Marco R, Di Tullio, Susan, Graham, Douglas L, Mann, Ralph L, Sacco, J P, Mohr, Gregory Y H, Lip, Arthur J, Labovitz, Seitetz C, Lee, Piotr, Ponikowski, Dirk J, Lok, Stefan D, Anker, John L P, Thompson, Shunichi, Homma
Publikováno v: JACC. Heart failure. 5(8)
The aim of this study was to determine whether aspirin increases heart failure (HF) hospitalization or death in patients with HF with reduced ejection fraction receiving an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e265d43b52ee0661cb9263c09d8e8c9d
https://pubmed.ncbi.nlm.nih.gov/28774397
Zobrazit plný text záznamu
7
Excellent inter-rater, intra-rater, and telephone-administered reliability of the ALSFRS-R in a multicenter clinical trial
Autor: Petra Kaufmann, Gilbero Levy, Jacquelina Montes, Richaro Buchsbaum, Alexandra I. Barsdorf, Vanessa Battista, Rachel Arbing, Paul H. Gordon, Hiroshi Mitsumoto, Brvce Levin, John L. P. Thompson
Publikováno v: Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 8(1)
We wished to determine whether the Amyotrophic Lateral Sclerosis Functional Rating Scale-revised (ALSFRS-R) is reliable when used as primary outcome measure in a multicenter clinical trial. To establish inter-rater reliability, we randomly assigned 1
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9e6343305bc2ccca04b99dfe2543ec0
https://pubmed.ncbi.nlm.nih.gov/17364435
Zobrazit plný text záznamu
8
ALS issues in clinical trials. Missing data
Autor: John L P, Thompson, Gilberto, Levy
Publikováno v: Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases. 5
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::db07e42f6082fce97548546d2d2c092d
https://pubmed.ncbi.nlm.nih.gov/15512872
Zobrazit plný text záznamu
9
Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial
Autor: Ralph L. Sacco, Janet T. DeRosa, E. Clarke Haley, Jr, Bruce Levin, Paul Ordronneau, Stephen J. Phillips, Tanja Rundek, Rose G. Snipes, John L. P. Thompson, null for the GAIN Americas Investigators
Publikováno v: JAMA. 285(13)
ContextElucidation of the ischemic cascade has helped stimulate development of neuroprotective drugs aimed at limiting brain injury in the hours following an ischemic stroke. To date, none of these drugs has shown clinical efficacy.ObjectiveTo examin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bb80f7bab13ff1fb4d29cb6ab3dfe19
https://pubmed.ncbi.nlm.nih.gov/11277833
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje